Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Amoxapine chemical structure | |
IUPAC name | |
CAS number 14028-44-5 |
ATC code |
PubChem 2170 |
DrugBank APRD00142 |
Chemical formula | {{{chemical_formula}}} |
Molecular weight | 313.781 |
Bioavailability | ? |
Metabolism | Hepatic (cytochrome P450 system) |
Elimination half-life | 8-10 hours (30 hours for major metabolites) |
Excretion | Renal |
Pregnancy category | {{{pregnancy_category}}} |
Legal status | {{{legal_status}}} |
Routes of administration | Oral |
Amoxapine (brand-names Asendin®, Asendis®, Defanyl®, Demolox®, Moxadil®) is a tetracyclic antidepressant of the dibenzoxazepine class. It is used in the treatment of depression, panic disorders and bipolar disorder.
Amoxapine is a strong reuptake inhibitor of norepinephrine and weak reuptake inhibitor of serotonin. One of its major metabolites, 7-hydroxyamoxapine, has a dopamine receptor blocking effect.
References[]
- Mosby Year-Book, Inc. (1995). Physician's GenRx: The Complete Drug Reference (5th Ed.). Riverside, CT: Denniston Publishing Co.
- Palfai, T. & Jankiewicz, H. (1997). Drugs and Human Behavior (2nd Ed.). Madison, WI: Brown & Benchmark.
- Hedges, D. & Burchfield, C. (2006). Mind, Brain, and Drug: An Introduction to Psychopharmacology. Boston, MA: Pearson.
- fr:Amoxapine
- ja:アモキサピン
This page uses Creative Commons Licensed content from Wikipedia (view authors). |